Ducommun Inc
Valuation each multiple against its own 5-year range
Vs. peers Aerospace & Defense
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| Ducommun Inc (DCO) | 2.03B | 38.59 | 2.84 | 0.00% |
| SpaceX (SPCX) | 1.74T | -505.10 | 9.82 | 0.00% |
| GE Aerospace (GE) | 319.95B | 36.13 | 18.26 | 0.57% |
| RTX Corp (RTX) | 256.62B | 30.92 | 3.71 | 1.48% |
| Lockheed Martin (LMT) | 130.63B | 20.08 | 12.98 | 2.44% |
| Boeing (BA) | 123.54B | 16.09 | 18.89 | 0.00% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 7.6% below Morningstar's fair value estimate.
Fair value
Ducommun Inc receives a 3-star quantitative star rating, reflecting our opinion that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 3% discount to our quantitative fair value estimate of $144.14 per share; however, some caution is warranted due to this estimate's medium uncertainty rating.
The firm's solid growth increases our fair value estimate. Consistent revenue and earnings growth indicates a company's potential for increased market share and profitability. Reflecting the firm's growth is its EPS 5-year growth of 13.2%, which ranks in the top 40% globally. The robust five-year track record of EPS growth is reason to be optimistic about the firm's shares. We believe this is a sign that shares could be undervalued.
Alternatively, the company's valuation metrics are potentially concerning. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's book value yield of 34.9%, a core component of valuation, lies in the bottom 30% compared with peers globally. The market value of this company's shares looks expensive relative to the book (accounting) value of equity, which, despite our favorable price/fair value ratio, is a negative attribute.
Economic moat
The narrow moat rating for this company indicates investors can expect it to generate 10 years or more of excess returns on capital due to its respectable competitive advantages. In addition, the company's moderate financial health score is decent and doesn't seriously concern us with regard to financial distress.
By Quantitative Equity Report
Quote time 2026-11-20 20:02:25 · For reference only, not investment advice and not tailored to your situation.
Ducommun Inc discussion 0 comments